Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
October 16 2009 - 9:00AM
PR Newswire (US)
IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Endologix, Inc.
(NASDAQ: ELGX), developer of minimally invasive treatments for
aortic disorders, announced today details relating to the release
of its third quarter 2009 financial results, which will take place
on Tuesday, October 27, 2009 after the close of the market.
Endologix will hold a conference call on Tuesday, October 27, 2009
at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in
numbers are (877) 407-0789 for domestic callers and (201) 689-8562
for international callers. A live Web cast of the conference call
will be available online from the investor relations page of the
Company's corporate website at http://www.endologix.com/. After the
live Web cast, the call will remain available on Endologix's Web
site, http://www.endologix.com/, through November 27, 2009. In
addition, a telephonic replay of the call will be available until
November 3, 2009. The replay dial-in numbers are (877) 660-6853 for
domestic callers and (201) 612-7415 for international callers.
Please use account number 3055 and conference ID number 335438.
About Endologix Endologix, Inc. develops and manufactures minimally
invasive treatments for aortic disorders. The Company's flagship
product is the Powerlink® System, which is an endovascular stent
graft for the treatment of abdominal aortic aneurysms (AAA). AAA is
a weakening of the wall of the aorta, the largest artery in the
body, resulting in a balloon-like enlargement. Once AAA develops,
it continues to enlarge and, if left untreated, becomes
increasingly susceptible to rupture. The overall patient mortality
rate for ruptured AAA is approximately 75%, making it a leading
cause of death in the U.S. Additional information can be found on
Endologix's Web site at http://www.endologix.com/. COMPANY CONTACT:
INVESTOR CONTACTS: Endologix, Inc. The Ruth Group John McDermott,
CEO Nick Laudico (646) 536-7030 (949) 595-7200 Zack Kubow (646)
536-7020 http://www.endologix.com/ DATASOURCE: Endologix, Inc.
CONTACT: COMPANY CONTACT, John McDermott, CEO, Endologix, Inc.,
+1-949-595-7200, http://www.endologix.com/, INVESTOR CONTACTS, Nick
Laudico, +1-646-536-7030, or Zack Kubow +1-646-536-7020, both of
The Ruth Group Web Site: http://www.endologix.com/
Copyright